Delving into the Latest Updates on PharmaNess Neuroscience with Synapse

Overview

Tags

Nervous System Diseases

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Nervous System Diseases	1

Top 5 Drug Type	Count

Small molecule drug	1

Top 5 Target	Count

CB2(Cannabinoid CB2 receptor)	1

Cogent evidence shows that cannabis plays a variable role on behavioral regulation and the pathophysiology of most psychiatric conditions. Accordingly, cannabis has been alternatively shown to exacerbate or ameliorate mental symptoms, depending on its composition and route of consumption, as well as specific individual and contextual characteristics. The vulnerability to the psychological effects of cannabis is influenced by a complex constellation of genetic and environmental factors. In the present article, we will review the current evidence on the pharmacological, individual and situational factors that have been documented to affect the behavioral and psychiatric effects of cannabinoids.

100 Deals associated with PharmaNess Neuroscience

Login to view more data

100 Translational Medicine associated with PharmaNess Neuroscience

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 20 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Preclinical

1

4

Other

Login to view more data

Current Projects

Drug(Targets)	Indications	Global Highest Phase

NESS400 ( CB2 )	Neuralgia More	Preclinical
NESS-200P	Psychotic Disorders More	Pending
NESS-11-SM ( CB1R )	Obesity More	Pending
NESS 29-64FD ( CHRNA4 x CHRNB2 )	Neurodegenerative Diseases More	Pending
NESS-117-OPB ( μ opioid receptor )	Pain More	Pending